Redwood AI Corp. (RDWCF)

Redwood AI Corp. provides artificial intelligence (AI)-based software and analytics solutions for chemical and pharmaceutical development. The company's platform integrates AI models, cheminformatics, and operational data to support synthesis planning, process optimization, and supply-chain decision-making, helping reduce time, cost, and risk from early development through commercialization. It serves the pharmaceuticals, biotechnology, and material sciences industries. The company has a strategic collaboration with the University of British Columbia for the development of AI-driven drug discovery solutions targeting Alzheimer's disease and for the development of AI models to enhance its chemical synthesis platform. The company was formerly known as Marshall Technologies Corp. The company is based in Vancouver, Canada.